Role of bcl-XL in the control of apoptosis in murine myeloma cells

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1451-1456

  Gauthier, Eric R ^a,c   Piché, Lyson ^a   Lemieux, Gérald ^a,b   Lemieux, Réal ^a,b  

^a Canadian Red Cross Society   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAURENTIAN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE ACTIVATION; GENE EXPRESSION; GROWTH INHIBITION; MYELOMA CELL; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; CYCLOHEXIMIDE; GENE EXPRESSION; HYBRIDOMAS; MICE; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; PLASMACYTOMA; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029880038     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bursch, W , Kleine, L., and Tenniswood, M. The biochemistry of cell death by apoptosis. Biochem. Cell Biol , 68: 1071-1074, 1990
2. Cotter, T. G., Lennon, S V., Glynn, J G., and Martin, D J Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res., 10: 1153-1160, 1990.
3. Reed, J C Bcl-2 and the regulation of programmed cell death. J Cell Biol., 124: 1-6, 1994.
4. Korsmeyer, S J. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 10: 785-807, 1992
5. Vaux, D. L., Cory, S., and Adams, J. M Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335. 440-442, 1988.
6. Nunez, G., London, L , Hockenberry, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines J. Immunol., 144, 3602-3610, 1990.
7. Cory, S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13: 513-543, 1995.
8. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E , Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74. 597-608, 1993.
9. Reynolds, J. E , Yang, T., Qiau, L., Jenbensore, J. D , Zhou, P., Eastman, A., and Craig, R. W. Mcl-1, a member of the bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res., 54: 6348-6352, 1994.
10. L rescues WEHI-231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155: 66-75, 1995.
11. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur J. Immunol., 25: 1352-1357, 1995.
12. Schlaifer, D., March, M , Krajewski, S., Laurent, G., Pris, J., Delsol, G., Reed, J. C., and Roussel, P. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease Blood, 85: 2671-2674, 1995.
13. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res, 55: 2576-2582, 1995
14. Oltvai, Z N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
15. Farrow, S. N., White, J. H. M., Martinou, I , Raven, T., Pun, K-T., Grinham, C. J., Martinou, J. C., and Brown, R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (Lond.), 374: 731-733, 1995.
16. L and Bcl-2, displaces Box and promotes cell death. Cell, 80: 285-291, 1995.
17. Evan, G I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C M , Penn, L. Z , and Hancock, D C. Induction of apoptosis in fibroblasts by c-myc protein Cell, 69: 119-128, 1992.
18. Yonish-Ronach, E., Resnitzky, D , Lotem, J., Sachs, L., Kinichi, A , and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352, 345-347, 1991.
19. MacLennan, I. C. M. Germinal centres. Annu. Rev. Immunol., 12: 117-139, 1994.
20. Williams, G. T. Programmed cell death: apoptosis and oncogenesis. Cell, 65: 1097-1098, 1991
21. Harrington, E. A., Fanidi, A , and Eva, G. I. Oncogenes and cell death. Curr. Opin. Genet. & Dev., 4: 120-129, 1994
22. Potter, M. Immunoglobulin producing tumors and myeloma proteins of mice Physiol. Rev., 52. 631-719, 1972.
23. Sheng-Ong, G. L C , Keath, E. J , Piccoli, S P , and Cole, M D. Novel myc oncogene RNA from abortive immunoglobulin recombination in mouse plasmacytomas Cell, 31: 443-452, 1982
24. Hirano, T., Abira, S., Taga, T , and Kishimoto, T Biological and clinical aspects of interleukin-6. Immunol. Today. 11: 443-449, 1990
25. Muller, J. R., Potter, M , and Janz, S Difference in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells Proc Natl. Acad. Sci. USA, 91: 12066-12070, 1994.
26. McGahon, A., Bissonnette, R P , Schmitt, M , Cotter, K. M., Green, D. R., and Cotter, T. G. BCR-ABL maintains resistance of chrome myelogenous leukemia cells to apoptotic cell death. Blood, 83: 1179-1187, 1994.
27. Rosenbaum, H., Harris, A. W , Bath, M. I , McNeall, J., Webb, J., Adams, J M., and Cory, S. An Eμ-v-abl transgene elicits plasmacytomas in concert with an activated myc gene EMBO J., 9 897-905, 1990
28. L. Cancer Res., 55. 2262-2265, 1995.
29. Ray, S., and Diamond, B. Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis Proc. Natl. Acad. Sci. USA, 91: 5548-5551, 1994
30. Perreault, J , and Lemieux, R. Rapid apoptotic cell death of B-cell hybridomas in absence of gene expression. J Cell. Physiol , 156. 286-293, 1993.
31. Martel, F , Bazin, R., Verrette, S., and Lemieux, R Characterization of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane Ig. J. Immunol. 141. 1624-1629, 1988
32. Hansen, M. B., Nielsen, S. E , and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol. Methods, 119: 203-210, 1989.
33. Darveau, A., Pelletier, J., and Sonenberg, N Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in their 5′ untranslated region Proc. Natl Acad. Sci. USA, 82. 2315-2319, 1985.
34. Miyashita, T., and Reed, J. C. Bcl-2 gene transfer increases relative resistance of S49 1 and WEHI 7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res , 52: 5407-5411, 1992.
35. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987
36. Sambrook, J., Fritsch, E. F., and Maniatis, T Molecular Cloning. A Laboratory Manual, Ed. 2, pp. 8.11-8.13. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989
37. Johansen, T. E , Scholler, M. S., Tolstoy, S., and Schwartz, T. W. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett., 267: 289-293, 1990.
38. +) RNA. Biotechniques. 6: 114-116, 1988.
39. Khandjian, E. Crosslinking of RNA to nylon membranes enhances hybridization signals Mol. Biol. Rep., 11: 107-115, 1986.
40. Gurfinkel, N., Unger, T., Givol, D., and Muchinski, J. F Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific. Eur J. Immunol., 17: 567-570, 1987
41. Horibata, K., and Harris, A W. Mouse myelomas and lymphomas in culture. Exp. Cell Res , 60: 61-77, 1970.
42. Kohler, G , and Milstein, C Continuous culture of fused cells secreting antibody of predefined specificity. Nature (Lond), 256: 495-497, 1975.
43. Shulman, M., Wilde, C. D., and Kohler, G. A better cell line for making hybridomas secreting specific antibodies. Nature (Lond.), 276: 269-270, 1978.
44. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans. J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-X but not bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7350-7354, 1994.
45. Mryashita, T., and Reed, J C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
46. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S , Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of bcl-X expression. Cancer Res., 54: 5501-5507, 1994.
47. Strasser, A., Whittingham, S , Vaux, D L., Bath, M. L., Adams, J. M., Cory, S., and Harris, A. W. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease Proc. Natl. Acad. Sci. USA, 88: 8611-8665, 1991.
48. Liu, Y. J., Mason, D. Y., Johnson, G. D., Abbot, S., Gregory, C. D., Hardie, D. L., Gordon, J., and MacLennan, I. C. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol., 21: 1905-1910, 1991.